Latest Insider Transactions at Chromocell Therapeutics Corp (CHRO)
This section provides a real-time view of insider transactions for Chromocell Therapeutics Corp (CHRO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Chromocell Therapeutics Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Chromocell Therapeutics Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2024
|
Knuettel Francis Ii CEO, Pres., CFO, Treas & Secty |
BUY
Open market or private purchase
|
Indirect |
3,500
+0.64%
|
$0
$0.97 P/Share
|
|
Sep 12
2024
|
Knuettel Francis Ii CEO, Pres., CFO, Treas & Secty |
BUY
Open market or private purchase
|
Indirect |
1,700
+0.31%
|
$0
$0.97 P/Share
|
|
Sep 12
2024
|
Richard Malamut Director |
BUY
Open market or private purchase
|
Indirect |
10,400
+10.2%
|
$0
$0.94 P/Share
|
|
Sep 11
2024
|
Knuettel Francis Ii CEO, Pres., CFO, Treas & Secty |
BUY
Open market or private purchase
|
Indirect |
5,500
+1.0%
|
$0
$0.94 P/Share
|
|
Sep 10
2024
|
Knuettel Francis Ii CEO, Pres., CFO, Treas & Secty |
BUY
Open market or private purchase
|
Indirect |
6,500
+1.2%
|
$0
$0.89 P/Share
|
|
Jun 28
2024
|
Knuettel Francis Ii CEO, Pres., CFO, Treas & Secty |
SELL
Bona fide gift
|
Direct |
20,000
-1.88%
|
-
|
|
Feb 21
2024
|
Todd C Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,167
+50.0%
|
$116,668
$4.8 P/Share
|
|
Feb 21
2024
|
Ezra M Friedberg Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,641
+1.96%
|
$82,564
$4.8 P/Share
|